GoodRx Holdings, Inc(NASDAQ:GDRX) 
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools to enables consumers compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant presc...
Website: https://www.goodrx.com/
Founded: 2011
IPO Price: $33 (Sep 23, 2020)
Full Time Employees: 735 (Sep 2022)
CEO: Douglas Joseph Hirsch / Trevor Bezdek
Sector: Healthcare
Industry: Health Information Services
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 194,006,000 | 194,785,000 | 196,028,000 | 203,070,000 | 202,970,000 | 198,583,000 | 195,251,000 | 200,610,000 | 197,880,000 | 196,644,000 | 179,958,000 | 189,677,000 | 183,986,000 | 184,109,000 | 187,318,000 | 191,798,000 | 203,329,000 | 213,256,000 | 195,102,000 | 176,635,000 | 160,431,000 | 153,544,000 | 140,453,000 |
yoy | -4.42% | -1.91% | 0.40% | 1.23% | 2.57% | 0.99% | 8.50% | 5.76% | 7.55% | 6.81% | -3.93% | -1.11% | -9.51% | -13.67% | -3.99% | 8.58% | 26.74% | 38.89% | 38.91% | ||||
qoq | -0.40% | -0.63% | -3.47% | 0.05% | 2.21% | 1.71% | -2.67% | 1.38% | 0.63% | 9.27% | -5.12% | 3.09% | -0.07% | -1.71% | -2.34% | -5.67% | -4.65% | 9.30% | 10.45% | 10.10% | 4.49% | 9.32% | |
costs and operating expenses: | |||||||||||||||||||||||
cost of revenue, exclusive of depreciation and amortization presented separately below | 20,156,000 | 17,464,000 | 13,419,000 | 13,350,000 | 13,364,000 | 12,193,000 | 11,684,000 | 11,870,000 | 12,468,000 | 15,170,000 | 18,721,000 | 16,339,000 | 16,695,000 | 17,360,000 | 17,395,000 | 18,044,000 | 12,280,000 | 13,927,000 | 11,271,000 | 11,090,000 | 10,428,000 | 9,204,000 | 7,540,000 |
product development and technology | 30,177,000 | 28,939,000 | 31,012,000 | 29,933,000 | 31,142,000 | 31,739,000 | 30,139,000 | 30,854,000 | 31,017,000 | 32,032,000 | 39,611,000 | 31,285,000 | 32,908,000 | 36,770,000 | 35,921,000 | 35,404,000 | 35,042,000 | 35,060,000 | 35,073,000 | 29,567,000 | 26,160,000 | 23,683,000 | 15,846,000 |
sales and marketing | 81,053,000 | 78,616,000 | 83,532,000 | 84,870,000 | 84,542,000 | 93,829,000 | 89,867,000 | 93,454,000 | 89,964,000 | 93,751,000 | 91,615,000 | 77,440,000 | 78,522,000 | 84,128,000 | 86,215,000 | 94,338,000 | 92,950,000 | 106,491,000 | 95,651,000 | 88,381,000 | 79,694,000 | 74,940,000 | 65,113,000 |
general and administrative | 26,819,000 | 23,937,000 | 32,014,000 | 28,379,000 | 29,630,000 | 23,546,000 | 25,619,000 | 27,589,000 | 41,108,000 | 30,371,000 | 35,317,000 | 30,208,000 | 29,619,000 | 28,581,000 | 49,548,000 | 34,740,000 | 31,923,000 | 35,374,000 | 35,947,000 | 39,579,000 | 43,786,000 | 340,753,000 | 108,479,000 |
depreciation and amortization | 21,792,000 | 23,146,000 | 21,431,000 | 19,729,000 | 20,912,000 | 19,096,000 | 17,535,000 | 16,965,000 | 15,942,000 | 43,608,000 | 33,024,000 | 16,097,000 | 14,939,000 | 15,533,000 | 13,952,000 | 13,319,000 | 11,373,000 | 10,648,000 | 10,161,000 | 8,369,000 | 5,361,000 | 4,404,000 | 5,160,000 |
total costs and operating expenses | 179,997,000 | 172,102,000 | 181,408,000 | 176,261,000 | 179,590,000 | 180,403,000 | 174,844,000 | 180,732,000 | 190,499,000 | 214,932,000 | 218,288,000 | 171,369,000 | 172,683,000 | 182,372,000 | 203,031,000 | 195,845,000 | 183,568,000 | 201,500,000 | 188,103,000 | 176,986,000 | 165,429,000 | 452,984,000 | 202,138,000 |
operating income | 14,009,000 | 22,683,000 | 14,620,000 | 26,809,000 | 23,380,000 | 18,180,000 | 20,407,000 | 19,878,000 | 7,381,000 | -18,288,000 | -38,330,000 | 18,308,000 | 11,303,000 | 1,737,000 | -15,713,000 | -4,047,000 | 19,761,000 | 11,756,000 | 6,999,000 | -351,000 | -4,998,000 | -299,440,000 | -61,685,000 |
yoy | -40.08% | 24.77% | -28.36% | 34.87% | 216.76% | -199.41% | -153.24% | 8.58% | -34.70% | -1152.85% | 143.94% | -552.38% | -42.80% | -85.22% | -324.50% | 1052.99% | -495.38% | -103.93% | -111.35% | ||||
qoq | -38.24% | 55.15% | -45.47% | 14.67% | 28.60% | -10.91% | 2.66% | 169.31% | -140.36% | -52.29% | -309.36% | 61.97% | 550.72% | -111.05% | 288.26% | -120.48% | 68.09% | 67.97% | -2094.02% | -92.98% | -98.33% | 385.43% | |
operating margin % | 7.22% | 11.65% | 7.46% | 13.20% | 11.52% | 9.15% | 10.45% | 9.91% | 3.73% | -9.30% | -21.30% | 9.65% | 6.14% | 0.94% | -8.39% | -2.11% | 9.72% | 5.51% | 3.59% | -0.20% | -3.12% | -195.02% | -43.92% |
other expense, net: | |||||||||||||||||||||||
interest income | 1,397,000 | 1,889,000 | 2,309,000 | 2,803,000 | 3,932,000 | 4,587,000 | 4,797,000 | 6,334,000 | 7,555,000 | 8,474,000 | 8,649,000 | 7,814,000 | 7,234,000 | 13,103,000 | -2,920,000 | -857,000 | -52,000 | -17,000 | -13,000 | -13,000 | -16,000 | -20,000 | -24,000 |
interest expense | -9,767,000 | -10,403,000 | -10,829,000 | -10,729,000 | -10,644,000 | -11,358,000 | -12,355,000 | -14,566,000 | -14,643,000 | -14,821,000 | -14,720,000 | -14,054,000 | -13,133,000 | -56,559,000 | 9,478,000 | 6,969,000 | 5,869,000 | 5,903,000 | 5,928,000 | 5,906,000 | 5,905,000 | 6,216,000 | 6,264,000 |
total other expense | -8,370,000 | -8,490,000 | -8,520,000 | -7,232,000 | -6,712,000 | -6,771,000 | -12,295,000 | -8,232,000 | -7,088,000 | -6,347,000 | -8,271,000 | -6,240,000 | -7,707,000 | -43,456,000 | 6,558,000 | 6,112,000 | 5,817,000 | 5,886,000 | 5,915,000 | 5,893,000 | 5,889,000 | 6,194,000 | 6,241,000 |
income before income taxes | 5,639,000 | 14,193,000 | 6,100,000 | 19,577,000 | 16,668,000 | 11,409,000 | 8,112,000 | 11,646,000 | 293,000 | -24,635,000 | -46,601,000 | 12,068,000 | 3,596,000 | -4,745,000 | -22,271,000 | -10,159,000 | 13,944,000 | 5,870,000 | 1,084,000 | -6,244,000 | -10,887,000 | ||
income tax provision | -4,470,000 | -8,768,000 | -4,981,000 | -6,734,000 | -5,616,000 | -4,669,000 | -4,147,000 | -4,952,000 | -1,302,000 | -1,234,000 | 8,106,000 | 46,718,000 | -6,886,000 | 2,773,000 | -19,463,000 | 8,744,000 | -1,651,000 | -45,784,000 | -19,153,000 | 37,305,000 | 12,555,000 | 7,360,000 | 17,894,000 |
net income | 1,169,000 | 5,425,000 | 1,119,000 | 12,843,000 | 11,052,000 | 6,740,000 | 3,965,000 | 6,694,000 | -1,009,000 | -25,869,000 | -38,495,000 | 58,786,000 | -3,290,000 | -1,972,000 | -41,734,000 | -1,415,000 | 12,293,000 | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -298,274,000 | -50,032,000 |
yoy | -89.42% | -19.51% | -71.78% | 91.86% | -1195.34% | -126.05% | -110.30% | -88.61% | -69.33% | 1211.82% | -7.76% | -4254.49% | -126.76% | -95.06% | 130.97% | -104.56% | 636.99% | -86.62% | -63.89% | ||||
qoq | -78.45% | 384.81% | -91.29% | 16.21% | 63.98% | 69.99% | -40.77% | -763.43% | -96.10% | -32.80% | -165.48% | -1886.81% | 66.84% | -95.27% | 2849.40% | -111.51% | -130.80% | 120.90% | -158.17% | 1762.17% | -100.56% | 496.17% | |
net income margin % | 0.60% | 2.79% | 0.57% | 6.32% | 5.45% | 3.39% | 2.03% | 3.34% | -0.51% | -13.16% | -21.39% | 30.99% | -1.79% | -1.07% | -22.28% | -0.74% | 6.05% | -18.72% | -9.26% | 17.58% | 1.04% | -194.26% | -35.62% |
earnings per share: | |||||||||||||||||||||||
basic | 0.02 | 0.04 | 0.03 | 0.01 | 0.01 | 0.02 | 0.01 | -0.09 | 0.14 | -0.01 | -0.018 | -0.1 | 0.03 | -0.1 | -0.04 | 0.08 | |||||||
diluted | 0.02 | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 | 0.01 | -0.09 | 0.14 | -0.01 | -0.018 | -0.1 | 0.03 | -0.09 | -0.04 | 0.07 | |||||||
weighted-average shares used for eps calculation | |||||||||||||||||||||||
basic | 340,531 | 356,327 | 346,776 | 356,623 | 379,196 | 385,737 | 379,667 | 376,254 | 413,437 | 412,221 | 412,429 | 412,956 | 412,135 | 414,739 | 409,981 | 411,223 | 408,363 | 406,170 | 274,696 | 241,061 | |||
diluted | 341,424 | 356,973 | 347,810 | 357,159 | 379,656 | 392,172 | 388,504 | 384,732 | 413,437 | 414,335 | 412,429 | 412,956 | 412,135 | 427,378 | 409,981 | 411,223 | 428,867 | 429,577 | 274,696 | 241,061 | |||
stock-based compensation included in costs and operating expenses: | |||||||||||||||||||||||
cost of revenue | 52 | 49 | 86 | 122 | 100 | 94 | 86 | 64 | 76 | 123 | 146 | 180 | 161 | 169 | 136 | 100 | -46 | 258 | 238 | 181 | 121 | 86 | 57 |
other income | 24,000 | 694,000 | |||||||||||||||||||||
loss on extinguishment of debt | -2,077,000 | ||||||||||||||||||||||
other expense | -2,660,000 | -2,200,000 | -1,808,000 | -2,000 | 1,000 | ||||||||||||||||||
loss per share: | |||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||
weighted-average shares used for eps calculation | |||||||||||||||||||||||
basic and diluted | 390,048 | 410,315 | 412,858 | ||||||||||||||||||||
net income attributable to common stockholders: | |||||||||||||||||||||||
basic | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,668,000 | -50,032,000 | |||||||||||||||||
diluted | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,715,000 | -50,032,000 | |||||||||||||||||
net income attributable to common stockholders | |||||||||||||||||||||||
basic | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,668,000 | -50,032,000 | |||||||||||||||||
diluted | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,715,000 | -50,032,000 | |||||||||||||||||
earnings per share: | |||||||||||||||||||||||
earnings per share - basic | -1.08 | -0.21 | |||||||||||||||||||||
earnings per share - diluted | -1.08 | -0.21 | |||||||||||||||||||||
other expense: | |||||||||||||||||||||||
income before income tax expense | 546,000 | -67,926,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||
current assets | |||||||||||||||||||||||
cash and cash equivalents | 235,710,000 | 261,820,000 | 273,529,000 | 281,318,000 | 300,981,000 | 448,346,000 | 423,777,000 | 524,903,000 | 533,295,000 | 672,296,000 | 794,905,000 | 761,988,000 | 761,075,000 | 757,165,000 | 728,786,000 | 730,540,000 | 845,427,000 | 941,109,000 | 912,023,000 | 894,703,000 | 990,463,000 | 968,691,000 | 1,075,024,000 |
accounts receivable | 232,721,000 | 235,746,000 | 203,738,000 | 189,027,000 | 160,117,000 | 145,934,000 | 130,803,000 | 161,774,000 | 144,769,000 | 143,608,000 | 121,146,000 | 123,378,000 | 116,442,000 | 117,141,000 | 120,886,000 | 122,878,000 | 123,281,000 | 118,080,000 | 98,511,000 | 87,004,000 | 74,399,000 | 68,729,000 | 63,518,000 |
prescription reimbursement assets | 753,530,000 | 98,331,000 | |||||||||||||||||||||
prepaid expenses and other current assets | 44,507,000 | 47,205,000 | 88,248,000 | 80,269,000 | 79,110,000 | 64,975,000 | 72,220,000 | 63,878,000 | 54,735,000 | 56,886,000 | 53,047,000 | 33,886,000 | 29,499,000 | 45,380,000 | 28,716,000 | 40,539,000 | 26,015,000 | 29,638,000 | 41,006,000 | 94,043,000 | 55,618,000 | 46,048,000 | 39,630,000 |
total current assets | 1,266,468,000 | 643,102,000 | 565,515,000 | 550,614,000 | 540,208,000 | 659,255,000 | 626,800,000 | 750,555,000 | 732,799,000 | 872,790,000 | 969,098,000 | 919,252,000 | 907,016,000 | 919,686,000 | 878,388,000 | 893,957,000 | 994,723,000 | 1,088,827,000 | 1,051,540,000 | 1,075,750,000 | 1,123,380,000 | 1,086,368,000 | 1,181,072,000 |
property and equipment | 11,742,000 | 12,268,000 | 11,276,000 | 10,732,000 | 11,512,000 | 12,664,000 | 13,625,000 | 14,495,000 | 15,341,000 | 15,932,000 | 16,879,000 | 17,923,000 | 18,767,000 | 19,820,000 | 22,287,000 | 22,877,000 | 22,564,000 | 21,612,000 | 21,837,000 | 22,105,000 | 22,693,000 | 23,057,000 | 16,757,000 |
goodwill | 430,331,000 | 430,331,000 | 421,719,000 | 421,719,000 | 421,719,000 | 410,769,000 | 410,769,000 | 410,769,000 | 410,769,000 | 410,769,000 | 412,117,000 | 412,117,000 | 412,117,000 | 412,117,000 | 415,256,000 | 415,256,000 | 334,642,000 | 329,696,000 | 329,696,000 | 320,196,000 | 261,116,000 | 261,116,000 | 261,116,000 |
intangible assets | 61,167,000 | 64,082,000 | 62,773,000 | 65,566,000 | 68,359,000 | 52,102,000 | 54,061,000 | 56,022,000 | 58,122,000 | 60,898,000 | 89,431,000 | 108,657,000 | 114,256,000 | 119,865,000 | 125,900,000 | 131,719,000 | 85,990,000 | 88,791,000 | 94,077,000 | 94,780,000 | 34,443,000 | 36,919,000 | 39,225,000 |
capitalized software | 140,191,000 | 139,261,000 | 142,118,000 | 138,287,000 | 130,576,000 | 124,781,000 | 119,898,000 | 111,774,000 | 103,980,000 | 95,439,000 | 91,979,000 | 93,478,000 | 83,047,000 | 70,072,000 | 71,299,000 | 61,700,000 | 52,505,000 | 44,987,000 | 39,254,000 | 31,996,000 | 25,944,000 | 19,800,000 | 15,400,000 |
operating lease right-of-use assets | 28,748,000 | 28,808,000 | 29,694,000 | 30,692,000 | 22,898,000 | 27,794,000 | 28,842,000 | 29,893,000 | 30,928,000 | 29,929,000 | 31,501,000 | 33,538,000 | 34,916,000 | 35,906,000 | 27,971,000 | 28,507,000 | 26,978,000 | 27,705,000 | 25,969,000 | 26,902,000 | 27,883,000 | 27,712,000 | 29,318,000 |
deferred tax assets | 53,042,000 | 57,111,000 | 69,093,000 | 77,182,000 | 77,182,000 | 77,182,000 | 65,910,000 | 65,268,000 | 65,268,000 | 65,268,000 | 57,695,000 | 62,686,000 | 45,824,000 | 12,971,000 | 13,344,000 | 13,117,000 | 1,687,000 | ||||||
other assets | 29,562,000 | 29,095,000 | 23,319,000 | 23,914,000 | 22,817,000 | 23,520,000 | 34,941,000 | 36,614,000 | 36,756,000 | 37,775,000 | 39,272,000 | 44,451,000 | 41,381,000 | 27,165,000 | 25,958,000 | 37,980,000 | 20,926,000 | 6,007,000 | 6,168,000 | 2,229,000 | 2,171,000 | 2,025,000 | 2,230,000 |
total assets | 2,021,251,000 | 1,404,058,000 | 1,325,507,000 | 1,318,706,000 | 1,295,271,000 | 1,388,067,000 | 1,354,846,000 | 1,475,390,000 | 1,453,963,000 | 1,588,800,000 | 1,707,972,000 | 1,692,102,000 | 1,611,500,000 | 1,604,631,000 | 1,567,059,000 | 1,591,996,000 | 1,538,328,000 | 1,607,625,000 | 1,614,365,000 | 1,586,929,000 | 1,510,974,000 | 1,470,114,000 | 1,546,805,000 |
liabilities and stockholders' equity | |||||||||||||||||||||||
current liabilities | |||||||||||||||||||||||
accounts payable | 14,525,000 | 19,405,000 | 28,725,000 | 25,411,000 | 15,258,000 | 14,137,000 | 12,391,000 | 16,884,000 | 33,518,000 | 36,266,000 | 32,905,000 | 6,795,000 | 12,389,000 | 17,700,000 | 10,855,000 | 16,825,000 | 12,820,000 | 17,501,000 | 17,279,000 | 18,378,000 | 15,101,000 | 10,291,000 | 14,014,000 |
prescription reimbursement liabilities | 750,978,000 | 130,139,000 | |||||||||||||||||||||
accrued expenses and other current liabilities | 83,719,000 | 86,705,000 | 143,372,000 | 95,677,000 | 77,567,000 | 99,130,000 | 92,677,000 | 73,172,000 | 70,843,000 | 71,329,000 | 74,554,000 | 66,001,000 | 47,730,000 | 47,523,000 | 61,025,000 | 49,766,000 | 33,812,000 | 50,732,000 | 42,447,000 | 33,759,000 | 34,944,000 | 37,692,000 | 36,093,000 |
current portion of debt | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 3,750,000 | 7,029,000 | 7,029,000 | 8,787,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 |
operating lease liabilities, current | 4,976,000 | 4,753,000 | 4,761,000 | 4,821,000 | 5,558,000 | 5,636,000 | 5,543,000 | 5,388,000 | 5,131,000 | 6,177,000 | 3,334,000 | 2,728,000 | 1,833,000 | 4,068,000 | 6,057,000 | 5,998,000 | 5,703,000 | 5,851,000 | 5,926,000 | 6,325,000 | 5,975,000 | 4,539,000 | 3,029,000 |
total current liabilities | 859,198,000 | 246,002,000 | 181,858,000 | 130,909,000 | 103,383,000 | 123,903,000 | 114,361,000 | 102,473,000 | 116,521,000 | 122,559,000 | 117,822,000 | 82,553,000 | 68,981,000 | 76,320,000 | 84,966,000 | 79,618,000 | 59,364,000 | 81,113,000 | 72,681,000 | 65,491,000 | 63,049,000 | 59,551,000 | 60,165,000 |
debt | 482,422,000 | 483,264,000 | 484,114,000 | 484,972,000 | 485,837,000 | 486,711,000 | 487,593,000 | 645,648,000 | 646,678,000 | 647,703,000 | 648,729,000 | 649,753,000 | 650,776,000 | 651,796,000 | 652,814,000 | 653,830,000 | 654,845,000 | 655,858,000 | 656,868,000 | 657,877,000 | 658,883,000 | 659,888,000 | 688,891,000 |
operating lease liabilities, net of current portion | 48,953,000 | 49,789,000 | 51,260,000 | 52,745,000 | 44,794,000 | 46,040,000 | 47,681,000 | 49,316,000 | 51,339,000 | 48,403,000 | 52,387,000 | 54,858,000 | 56,278,000 | 54,131,000 | 32,551,000 | 33,600,000 | 32,512,000 | 33,592,000 | 32,033,000 | 32,818,000 | 33,705,000 | 33,467,000 | 34,424,000 |
other liabilities | 8,692,000 | 8,741,000 | 7,563,000 | 7,049,000 | 6,910,000 | 6,755,000 | 8,777,000 | 8,554,000 | 8,356,000 | 8,177,000 | 7,761,000 | 9,567,000 | 7,997,000 | 7,557,000 | 7,675,000 | 6,553,000 | 4,703,000 | 5,138,000 | 6,387,000 | 6,349,000 | 6,278,000 | 5,849,000 | 5,144,000 |
total liabilities | 1,399,265,000 | 787,796,000 | 724,795,000 | 675,675,000 | 640,924,000 | 663,409,000 | 658,412,000 | 805,991,000 | 822,894,000 | 826,842,000 | 826,699,000 | 796,731,000 | 784,032,000 | 789,804,000 | 778,656,000 | 774,056,000 | 751,821,000 | 775,945,000 | 767,969,000 | 762,535,000 | 761,915,000 | 758,755,000 | 790,396,000 |
commitments and contingencies | |||||||||||||||||||||||
stockholders' equity | |||||||||||||||||||||||
preferred stock, 0.0001 par value... | |||||||||||||||||||||||
common stock, 0.0001 par value... | 34,000 | 34,000 | 34,000 | 35,000 | 36,000 | 38,000 | 38,000 | 38,000 | 38,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 39,000 | 39,000 | 39,000 | 39,000 | 39,000 |
additional paid-in capital | 2,031,357,000 | 2,026,802,000 | 2,016,677,000 | 2,060,114,000 | 2,084,272,000 | 2,165,633,000 | 2,144,149,000 | 2,121,079,000 | 2,089,443,000 | 2,219,321,000 | 2,312,767,000 | 2,288,370,000 | 2,279,253,000 | 2,263,322,000 | 2,234,926,000 | 2,222,729,000 | 2,189,881,000 | 2,247,347,000 | 2,222,150,000 | 2,182,079,000 | 2,137,805,000 | 2,101,773,000 | 1,848,549,000 |
accumulated deficit | -1,409,405,000 | -1,410,574,000 | -1,415,999,000 | -1,417,118,000 | -1,429,961,000 | -1,441,013,000 | -1,447,753,000 | -1,451,718,000 | -1,458,412,000 | -1,457,403,000 | -1,431,534,000 | -1,393,039,000 | -1,451,825,000 | -1,448,535,000 | -1,446,563,000 | -1,404,829,000 | -1,403,414,000 | -1,415,707,000 | -1,375,793,000 | -1,357,724,000 | -1,388,785,000 | -1,390,453,000 | -1,092,179,000 |
total stockholders' equity | 621,986,000 | 616,262,000 | 600,712,000 | 643,031,000 | 654,347,000 | 724,658,000 | 696,434,000 | 669,399,000 | 631,069,000 | 761,958,000 | 881,273,000 | 895,371,000 | 827,468,000 | 814,827,000 | 788,403,000 | 817,940,000 | 786,507,000 | 831,680,000 | 846,396,000 | 824,394,000 | 749,059,000 | 711,359,000 | 756,409,000 |
total liabilities and stockholders' equity | 2,021,251,000 | 1,404,058,000 | 1,325,507,000 | 1,318,706,000 | 1,295,271,000 | 1,388,067,000 | 1,354,846,000 | 1,475,390,000 | 1,453,963,000 | 1,588,800,000 | 1,707,972,000 | 1,692,102,000 | 1,611,500,000 | 1,604,631,000 | 1,567,059,000 | 1,591,996,000 | 1,538,328,000 | 1,607,625,000 | 1,614,365,000 | 1,586,929,000 | 1,510,974,000 | ||
deferred tax liabilities | 650,000 | 455,000 | 397,000 | 244,000 | 1,772,000 | ||||||||||||||||||
restricted cash | 2,900,000 | 2,900,000 | 2,900,000 | ||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders' equity | |||||||||||||||||||||||
redeemable convertible preferred stock | |||||||||||||||||||||||
common stock | |||||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders' equity | 1,470,114,000 | 1,546,805,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||
net income | 1,169,000 | 5,425,000 | 1,119,000 | 12,843,000 | 11,052,000 | 6,740,000 | 3,965,000 | -38,495,000 | 58,786,000 | -3,290,000 | -41,734,000 | -1,415,000 | 12,293,000 | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -298,274,000 | ||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||
depreciation and amortization | 21,792,000 | 23,146,000 | 21,431,000 | 19,729,000 | 20,912,000 | 19,096,000 | 17,535,000 | 16,965,000 | 15,942,000 | 43,608,000 | 33,024,000 | 16,097,000 | 14,939,000 | 15,533,000 | 13,952,000 | 13,319,000 | 11,373,000 | 10,648,000 | 10,161,000 | 8,369,000 | 5,361,000 | 4,404,000 |
amortization of debt issuance costs and discounts | 462,000 | 454,000 | 445,000 | 439,000 | 430,000 | |||||||||||||||||
non-cash operating lease expense | 925,000 | 944,000 | 998,000 | 979,000 | 1,086,000 | 1,203,000 | 1,051,000 | 1,035,000 | 895,000 | 1,082,000 | 967,000 | 1,013,000 | 1,042,000 | 1,035,000 | 805,000 | 782,000 | 727,000 | 651,000 | 660,000 | 919,000 | 872,000 | 1,047,000 |
stock-based compensation expense | 16,509,000 | 17,919,000 | 18,118,000 | 21,415,000 | 19,174,000 | 20,959,000 | 26,381,000 | 26,590,000 | 25,096,000 | 28,778,000 | 32,646,000 | 17,897,000 | 25,499,000 | 29,414,000 | 29,038,000 | 31,633,000 | 30,149,000 | 33,280,000 | 39,980,000 | |||
deferred income taxes | 4,069,000 | 11,982,000 | -11,272,000 | -7,573,000 | 4,991,000 | -63,015,000 | 35,000 | -356,000 | 195,000 | 58,000 | -394,000 | 46,068,000 | -32,853,000 | -137,000 | -227,000 | -13,202,000 | ||||||
loss on operating lease asset | 0 | 0 | 4,409,000 | |||||||||||||||||||
other | 798,000 | 1,334,000 | 20,000 | 170,000 | 286,000 | |||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||
accounts receivable | 3,025,000 | -30,212,000 | -14,711,000 | -28,910,000 | -14,183,000 | -15,131,000 | 30,971,000 | -17,005,000 | -1,161,000 | -22,462,000 | 2,232,000 | -6,936,000 | 699,000 | 3,745,000 | 1,992,000 | 836,000 | -5,198,000 | -19,569,000 | -11,507,000 | -7,203,000 | -5,670,000 | -5,211,000 |
prescription reimbursement assets | -655,199,000 | |||||||||||||||||||||
prepaid expenses and other assets | 2,177,000 | 14,846,000 | -7,437,000 | -2,309,000 | -13,487,000 | 18,595,000 | -6,287,000 | -9,320,000 | 3,339,000 | -2,295,000 | -16,293,000 | -7,569,000 | -6,005,000 | -10,507,000 | 5,302,000 | -12,055,000 | 3,616,000 | 11,364,000 | 52,937,000 | -37,397,000 | -9,844,000 | -9,103,000 |
accounts payable | -4,945,000 | -10,522,000 | 3,539,000 | 10,800,000 | 286,000 | 1,926,000 | -5,150,000 | -15,565,000 | -2,452,000 | 2,941,000 | 25,487,000 | -6,235,000 | -4,737,000 | 7,137,000 | -6,151,000 | 2,582,000 | -4,442,000 | -115,000 | -595,000 | -26,000 | 4,943,000 | -1,257,000 |
prescription reimbursement liabilities | 620,839,000 | |||||||||||||||||||||
accrued expenses and other current liabilities | 1,744,000 | -41,023,000 | 45,443,000 | 15,844,000 | -19,079,000 | 5,931,000 | 17,805,000 | 1,049,000 | 924,000 | -4,818,000 | 7,653,000 | 17,234,000 | 1,184,000 | -14,365,000 | 11,186,000 | 15,108,000 | -17,197,000 | 8,690,000 | 7,208,000 | -1,830,000 | -67,000 | 1,247,000 |
operating lease liabilities | -1,478,000 | -1,537,000 | -1,545,000 | -1,559,000 | -1,628,000 | -1,703,000 | -1,480,000 | -1,766,000 | -4,000 | -1,470,000 | -795,000 | -525,000 | -140,000 | -589,000 | -1,259,000 | -928,000 | -1,228,000 | -903,000 | -911,000 | -1,221,000 | 631,000 | 2,935,000 |
other liabilities | -49,000 | 1,178,000 | 514,000 | 139,000 | 155,000 | -2,022,000 | 223,000 | 198,000 | 179,000 | 416,000 | -1,806,000 | 1,899,000 | 405,000 | -412,000 | 2,937,000 | 35,000 | -435,000 | -1,249,000 | 38,000 | 71,000 | 429,000 | 1,374,000 |
net cash from operating activities | 11,838,000 | 32,888,000 | 76,023,000 | 49,580,000 | 9,413,000 | 44,743,000 | 86,862,000 | 9,701,000 | 42,586,000 | 15,868,000 | 60,270,000 | 29,866,000 | 32,288,000 | 31,879,000 | 33,732,000 | 51,049,000 | 30,120,000 | 49,810,000 | 48,558,000 | 34,926,000 | 45,485,000 | 14,850,000 |
capital expenditures | -21,644,000 | -15,830,000 | -17,999,000 | -18,315,000 | -21,876,000 | -16,644,000 | -15,859,000 | -17,229,000 | -12,872,000 | -13,647,000 | -14,959,000 | -8,537,000 | -15,290,000 | -13,775,000 | -13,731,000 | -12,418,000 | -9,259,000 | -8,510,000 | -6,993,000 | -9,695,000 | -9,810,000 | |
free cash flows | -9,806,000 | 17,058,000 | 58,024,000 | 31,265,000 | -12,463,000 | 28,099,000 | 71,003,000 | -7,528,000 | 2,996,000 | 46,623,000 | 14,907,000 | 23,751,000 | 16,589,000 | 19,957,000 | 37,318,000 | 17,702,000 | 40,551,000 | 40,048,000 | 27,933,000 | 35,790,000 | 5,040,000 | |
cash flows from investing activities | ||||||||||||||||||||||
purchase of property and equipment | -1,136,000 | -1,241,000 | -1,748,000 | -390,000 | -142,000 | -162,000 | -403,000 | -268,000 | -407,000 | -409,000 | -194,000 | -292,000 | -148,000 | -150,000 | -645,000 | -1,436,000 | -1,736,000 | -807,000 | -706,000 | -343,000 | -2,715,000 | -4,872,000 |
acquisition | 0 | 0 | -30,000,000 | |||||||||||||||||||
capitalized software | -20,508,000 | -14,589,000 | -16,251,000 | -17,925,000 | -21,734,000 | -16,482,000 | -15,456,000 | -16,961,000 | -20,208,000 | -12,463,000 | -13,453,000 | -14,667,000 | -14,140,000 | -15,140,000 | -13,130,000 | -12,295,000 | -10,682,000 | -8,452,000 | -7,804,000 | -6,650,000 | -6,980,000 | -4,938,000 |
net cash from investing activities | -21,644,000 | -31,770,000 | -17,999,000 | -18,315,000 | -51,876,000 | -16,644,000 | -15,859,000 | -17,229,000 | -20,615,000 | -12,872,000 | -13,647,000 | -14,959,000 | -14,288,000 | 1,286,000 | -13,775,000 | -163,608,000 | -34,401,000 | -9,259,000 | -27,058,000 | -132,721,000 | -9,695,000 | -9,810,000 |
cash flows from financing activities | ||||||||||||||||||||||
payments on long-term debt | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | 0 | -633,765,000 | -1,757,000 | -3,516,000 | 1,000 | -1,757,000 | -1,757,000 | -1,758,000 | -1,757,000 | -1,757,000 | -1,757,000 | -1,758,000 | -1,757,000 | -1,757,000 | -1,758,000 | -1,757,000 | -29,757,000 |
repurchases of class a common stock | -12,567,000 | -9,430,000 | -61,054,000 | -45,991,000 | -99,897,000 | -188,000 | -5,431,000 | 0 | -153,226,000 | -77,825,000 | -7,712,000 | -8,920,000 | -9,517,000 | 0 | -17,956,000 | 0 | -83,765,000 | |||||
proceeds from exercise of stock options | 95,000 | 0 | 58,000 | 1,000 | 2,000 | 611,000 | 6,663,000 | 9,188,000 | 2,584,000 | 1,556,000 | 3,118,000 | 559,000 | 708,000 | 49,000 | 1,271,000 | 4,156,000 | 3,683,000 | 5,306,000 | 14,234,000 | 13,109,000 | 2,372,000 | 195,000 |
employee taxes paid related to net share settlement of equity awards | -2,582,000 | -2,595,000 | -3,567,000 | -4,548,000 | -3,757,000 | -4,862,000 | -8,956,000 | -9,152,000 | -6,814,000 | -50,078,000 | -7,355,000 | -4,525,000 | -3,523,000 | -3,078,000 | -3,269,000 | -4,727,000 | -9,561,000 | -15,014,000 | -16,657,000 | -11,384,000 | -14,633,000 | |
net cash from financing activities | -16,304,000 | -12,827,000 | -65,813,000 | -50,928,000 | -104,902,000 | -3,530,000 | -172,129,000 | -864,000 | -160,972,000 | -125,605,000 | -13,706,000 | -13,994,000 | -14,090,000 | -4,786,000 | -21,711,000 | -2,328,000 | -91,401,000 | -11,465,000 | -4,180,000 | -865,000 | -14,018,000 | -111,373,000 |
net change in cash and cash equivalents | -26,110,000 | -11,709,000 | -7,789,000 | -19,663,000 | -147,365,000 | 24,569,000 | -101,126,000 | -8,392,000 | -139,001,000 | -122,609,000 | 32,917,000 | 913,000 | 3,910,000 | |||||||||
cash and cash equivalents | ||||||||||||||||||||||
beginning of period | 261,820,000 | 0 | 0 | 0 | 448,346,000 | 0 | 0 | 0 | 672,296,000 | 0 | 0 | 0 | 757,165,000 | 0 | 0 | 0 | 941,109,000 | 0 | 0 | 0 | 971,591,000 | |
end of period | 235,710,000 | -11,709,000 | -7,789,000 | -19,663,000 | 300,981,000 | 24,569,000 | -101,126,000 | -8,392,000 | 533,295,000 | -122,609,000 | 32,917,000 | 913,000 | 761,075,000 | 28,379,000 | -1,754,000 | -114,887,000 | 845,427,000 | 29,086,000 | 17,320,000 | -98,660,000 | 993,363,000 | |
supplemental disclosure of cash flow information | ||||||||||||||||||||||
non cash investing and financing activities: | ||||||||||||||||||||||
stock-based compensation included in capitalized software | 3,174,000 | 3,542,000 | 4,465,000 | 4,138,000 | 4,223,000 | 4,295,000 | 3,795,000 | 3,223,000 | 3,700,000 | 3,457,000 | 2,764,000 | 2,011,000 | 3,113,000 | 1,833,000 | 2,012,000 | |||||||
capitalized software included in accounts payable and accrued expenses and other current liabilities | 3,806,000 | 1,561,000 | 1,334,000 | 5,311,000 | 2,887,000 | 252,000 | 4,376,000 | 2,037,000 | 1,557,000 | 1,607,000 | 2,625,000 | |||||||||||
loss on extinguishment of debt | 0 | |||||||||||||||||||||
loss on operating lease assets | 979,000 | 0 | ||||||||||||||||||||
loss on disposal of capitalized software | 360,000 | |||||||||||||||||||||
loss on minority equity interest investment | 0 | 2,200,000 | 0 | 1,808,000 | ||||||||||||||||||
changes in operating assets and liabilities, net of effects of business acquisitions: | ||||||||||||||||||||||
acquisitions | ||||||||||||||||||||||
proceeds from long-term debt | 0 | 0 | ||||||||||||||||||||
payments of debt issuance costs | 0 | |||||||||||||||||||||
proceeds from employee stock purchase plan | 448,000 | 0 | 909,000 | 0 | 741,000 | 0 | ||||||||||||||||
right-of-use assets obtained in exchange for operating lease liabilities | 0 | |||||||||||||||||||||
amortization of debt issuance costs | 421,000 | 413,000 | 826,000 | 837,000 | 843,000 | 844,000 | 846,000 | 849,000 | 851,000 | 852,000 | 854,000 | 856,000 | 859,000 | 859,000 | 864,000 | 863,000 | 960,000 | |||||
change in fair value of contingent consideration | 1,200,000 | 16,617,000 | 1,167,000 | |||||||||||||||||||
gain on sale of business | ||||||||||||||||||||||
changes in operating assets and liabilities, net of effects of business acquisitions | ||||||||||||||||||||||
acquisitions, net of cash acquired | 0 | 0 | 0 | -14,540,000 | 0 | |||||||||||||||||
investment in minority equity interest | 0 | 0 | 0 | -15,007,000 | 0 | |||||||||||||||||
proceeds from sale of business | ||||||||||||||||||||||
changes in operating assets and liabilities | ||||||||||||||||||||||
capitalized software transferred from prepaid assets | 0 | 0 | 0 | 5,751,000 | ||||||||||||||||||
net loss | -1,009,000 | |||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||||||
payments for contingent consideration | ||||||||||||||||||||||
income tax paid (refunds received) | ||||||||||||||||||||||
interest paid | ||||||||||||||||||||||
right-of-use assets obtained in exchange for new operating lease liabilities | 20,180,000 | 0 | 2,387,000 | 52,000 | 0 | |||||||||||||||||
changes in operating assets and liabilities, net of effects of business acquisition | ||||||||||||||||||||||
acquisition, net of cash acquired | -6,976,000 | |||||||||||||||||||||
charitable stock donation | ||||||||||||||||||||||
proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions | 0 | |||||||||||||||||||||
proceeds from private placement with a related party | ||||||||||||||||||||||
payment of debt issuance costs and prepayment penalty | ||||||||||||||||||||||
payment for contingent consideration | 0 | 0 | ||||||||||||||||||||
payments of initial public offering issuance costs | -3,097,000 | |||||||||||||||||||||
proceeds from early exercise of stock options | 0 | |||||||||||||||||||||
net change in cash, cash equivalents and restricted cash | 28,379,000 | -1,754,000 | -114,887,000 | -95,682,000 | 29,086,000 | 17,320,000 | -98,660,000 | 21,772,000 | -106,333,000 | |||||||||||||
cash, cash equivalents and restricted cash | ||||||||||||||||||||||
conversion of preferred stock to common stock in connection with initial public offering | ||||||||||||||||||||||
loss on abandonment of operating lease assets | 650,000 | |||||||||||||||||||||
loss on abandonment and impairment of operating lease assets | ||||||||||||||||||||||
issuance of common stock | ||||||||||||||||||||||
income tax (refunds received) paid | ||||||||||||||||||||||
purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities | ||||||||||||||||||||||
proceeds from private placement | ||||||||||||||||||||||
payment of debt issuance costs | ||||||||||||||||||||||
non cash investing and financing activities | ||||||||||||||||||||||
offering costs included in accounts payable and accrued expense and other current liabilities | ||||||||||||||||||||||
stock-based compensation included in capitalized software development costs | 2,613,000 | 1,690,000 | 1,728,000 | 875,000 | ||||||||||||||||||
capitalized software development costs in accounts payable and accrued expenses and other current liabilities | 306,000 | |||||||||||||||||||||
employee tax withholding obligations on stock option exercises included in accrued expenses and other current liabilities | ||||||||||||||||||||||
stock-based compensation | 46,526,000 | 286,081,000 | ||||||||||||||||||||
capitalized software development costs in accrued expenses and other current liabilities | 615,000 | 98,000 | ||||||||||||||||||||
changes in operating assets and liabilities, net of effect of business acquisitions | ||||||||||||||||||||||
issuance of preferred stock | ||||||||||||||||||||||
dividends paid | ||||||||||||||||||||||
beginning of year | ||||||||||||||||||||||
end of year | ||||||||||||||||||||||
cash paid during the year for | ||||||||||||||||||||||
income taxes | ||||||||||||||||||||||
interest | ||||||||||||||||||||||
conversion of preferred stock to common stock | ||||||||||||||||||||||
offering costs included in accounts payable and accrued expenses and other current liabilities |